Cite

HARVARD Citation

    Cellini, L. et al. (2021). Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels. Journal of clinical psychopharmacology. 41 (6), pp. 694-696. [Online]. 
  
Back to record